| Country | China(P.R.C) |
| Tel | +86 - 133 9988 6714 |
| URL | www.pegbiocq.com |
In the past decade, Peg-Bio has been focusing on the development of recombinant biological drugs, mainly long-acting therapeutic enzymes and peptide drugs. Based on our successful track record of developing biological drugs, Peg-Bio provides high quality CRDMO services to over ten well-known biopharmaceutical companies. Our CRDMO unit is a multidisciplinary team and provides one-stop service for customers from drug discovery, CMC, IND to NDA. IMED Bioscience, a wholly owned subsidiary of Peg-Bio, focuses on the R&D, production and global sales of recombinant Proteases. Its fermentation scale reaches 3,000L and the whole production process is being managed in accordance with GMP. Featured with high purity, high specific activity, good stability, high per-batch yield and batch-to-batch consistency, IMED Bioscience’s recombinant proteases are favored by renowned biopharmaceutical companies and scientific research institutions worldwide.
moreEXHIBIT
COMPANY INTRODUCTION
In the past decade, Peg-Bio has been focusing on the development of recombinant biological drugs, mainly long-acting therapeutic enzymes and peptide drugs. Based on our successful track record of developing biological drugs, Peg-Bio provides high quality CRDMO services to over ten well-known biopharmaceutical companies. Our CRDMO unit is a multidisciplinary team and provides one-stop service for customers from drug discovery, CMC, IND to NDA. IMED Bioscience, a wholly owned subsidiary of Peg-Bio, focuses on the R&D, production and global sales of recombinant Proteases. Its fermentation scale reaches 3,000L and the whole production process is being managed in accordance with GMP. Featured with high purity, high specific activity, good stability, high per-batch yield and batch-to-batch consistency, IMED Bioscience’s recombinant proteases are favored by renowned biopharmaceutical companies and scientific research institutions worldwide.
